All In Biotech

Drug Trial Radar · NCT05455359

Gastrointestinal Dysmotility on Aspiration Risk

The Impact of Upper Gastrointestinal Dysmotility on Aspiration-associated Symptoms

Last checked: Nov 20, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Feb 13, 2025

Primary completion

May 31, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
Boston Children's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of developing aspiration-associated symptoms in children with neurologic impairment. The investigators are conducting a ten week cross over study comparing prucalopride to famotidine for the treatment of aspiration-associated symptoms.

Conditions

  • Esophageal Motility Disorders
  • Gastric Motor Dysfunction
  • Aspiration Pneumonia
  • Gastro Esophageal Reflux

Interventions

  • PrucaloprideDrug

    Prucalopride 0.04 mg/kg/day

  • FamotidineDrug

    Famotidine 0.4 mg/kg/day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pediatric Cough Quality of Life QuestionnaireTime frame: 4 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Boston Children's Hospital

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.